PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Immuneering Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-10 12:58 pm Sale |
2024-03-31 | 13G | Immuneering Corporation IMRX |
PRICE T ROWE ASSOCIATES INC | 910,266 3.100% |
-2,467,834 (-73.05%) |
Filing |
| 2024-02-14 10:03 am Sale |
2023-12-31 | 13G | Immuneering Corporation IMRX |
PRICE T ROWE ASSOCIATES INC | 3,378,100 11.500% |
-241,460 (-6.67%) |
Filing |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Immuneering Corporation IMRX |
PRICE T ROWE ASSOCIATES INC | 3,619,560 13.700% |
431,055 (+13.52%) |
Filing |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Immuneering Corporation IMRX |
PRICE T ROWE ASSOCIATES INC | 3,188,505 12.200% |
151,523 (+4.99%) |
Filing |
| 2021-08-10 1:37 pm Purchase |
2021-07-31 | 13G | Immuneering Corporation IMRX |
PRICE T ROWE ASSOCIATES INC | 3,036,982 12.400% |
3,036,982 (New Position) |
Filing |